| Geld | Brief | |
| Kurs | 69.02% | 71.02% |
| Volumen | 250'000.00 | 250'000.00 |
| Veränderung zum Vortag | -12.57% | -12.26% |
| Zeit | 13:25:07 | 13:25:07 |
| Datum | 19.03.2026 | 19.03.2026 |
| Währung | CHF | |
| Nennbetrag | 1'000.00 | |
| Handelsplatz | SIX Structured Products | |
| Lebenszyklus | Sekundärmarkt | |
| Tageshoch/-tief | 77.14 / 68.78 |
| Allzeithoch/-tief | 102.49 / 75.98 |
| Performance Strukturiertes Produkt seit Emission | -30.06% |
| Performance Basiswert seit Emission | -41.48% |
| Risiko | |
| SVSP VaR | n.v. |
| SVSP Risk Rating | n.v. |
| Volatilität | |
| Volatilität 30 Tage | 41.64% |
| Volatilität 100 Tage | 37.21% |
| Coupon p.a. | 10.50% |
| Barriere | 56.00% |
| Abstand zu Barriere | 4.31% |
| Barriere berührt | Nein |
| Cap | 59.72 |
| Abstand zu Cap | -70.88% |
| Maximale Rendite | 48.36% |
| Maximale Rendite p.a. | 159.04% |
| ZKB Barrier Reverse Convertible on worst of UBS Group AG/Helvetia Baloise Holding/Swiss Life Holding... 151092812 / CH1510928125 |
| ZKB Barrier Reverse Convertible on worst of Novartis AG/Geberit AG/UBS Group AG 151092088 / CH1510920882 |
| ZKB Callable Barrier Reverse Convertible on worst of Nestlé AG/Barry Callebaut AG/UBS Group AG/EMS-C... 149283732 / CH1492837328 |
| 10.0404% p.a. ZKB Callable Barrier Reverse Convertible, 19.08.2027 on worst of NESN SE/NOVN SE/ROP S... 151093164 / CH1510931640 |
| 9% p.a. ZKB Barrier Reverse Convertible, 23.02.2027 on worst of NOVN SE/ROP SE/UBSG SE 151093266 / CH1510932663 |